By calculating immunoreactivity scores based on the multiplication of positivity and intensity scores, we categorized samples into two groups: high SOX4 expression (immunoreactivity scores ≥ 4) and low SOX4 expression (immunoreactivity scores < 4) in RB tumors (Supplementary Fig. 6 and Table 1). This evidence concerns the gene SOX4 and retinoblastoma.